Skip to main content
Log in

Micafungin prophylaxis top in SCT

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Schonfeld W, Cheng JW, Tong KB, Seifeldin R.Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Clinical Therapeutics 30: 964-973, No. 5, May 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Micafungin prophylaxis top in SCT. Pharmacoecon. Outcomes News 558, 5 (2008). https://doi.org/10.2165/00151234-200805580-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805580-00014

Keywords

Navigation